Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/130371
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Berthier, Arnaud | es_ES |
dc.contributor.author | Paya, Miguel | es_ES |
dc.contributor.author | Garcia-Cabrero, A.M | es_ES |
dc.contributor.author | Ballester, María Inmaculada | es_ES |
dc.contributor.author | Heredia, Miguel | es_ES |
dc.contributor.author | Serratosa, J.M | es_ES |
dc.contributor.author | Sanchez, M.P | es_ES |
dc.contributor.author | Sanz, Pascual | es_ES |
dc.date.accessioned | 2016-03-22T12:55:03Z | - |
dc.date.available | 2016-03-22T12:55:03Z | - |
dc.date.issued | 2015-01-28 | - |
dc.identifier.citation | Molecular Neurobiology 53(2):1296-309. (2016) | es_ES |
dc.identifier.issn | 0893-7648 | - |
dc.identifier.uri | http://hdl.handle.net/10261/130371 | - |
dc.description | 14 páginas; 9 figuras. | es_ES |
dc.description.abstract | Lafora disease (LD, OMIM 254780) is a rare fatal neurodegenerative disorder that usually occurs during childhood with generalized tonic-clonic seizures, myoclonus, absences, drop attacks or visual seizures. Unfortunately, at present, available treatments are only palliatives and no curative drugs are available yet. The hallmark of the disease is the accumulation of insoluble polyglucosan inclusions, called Lafora bodies (LBs), within the neurons but also in heart, muscle and liver cells. Mouse models lacking functional EPM2A or EPM2B genes (the two major loci related to the disease) recapitulate the Lafora disease phenotype: they accumulate polyglucosan inclusions, show signs of neurodegeneration and have a dysregulation of protein clearance and endoplasmic reticulum stress response. In this study, we have subjected a mouse model of LD (Epm2b-/-) to different pharmacological interventions aimed to alleviate protein clearance and endoplasmic reticulum stress. We have used two chemical chaperones, trehalose and 4-phenylbutyric acid. In addition, we have used metformin, an activator of AMP-activated protein kinase (AMPK), as it has a recognized neuroprotective role in other neurodegenerative diseases. Here, we show that treatment with 4-phenylbutyric acid or metformin decreases the accumulation of Lafora bodies and polyubiquitin protein aggregates in the brain of treated animals. 4-Phenylbutyric acid and metformin also diminish neurodegeneration (measured in terms of neuronal loss and reactive gliosis) and ameliorate neuropsychological tests of Epm2b-/- mice. As these compounds have good safety records and are already approved for clinical uses on different neurological pathologies, we think that the translation of our results to the clinical practice could be straightforward. | es_ES |
dc.description.sponsorship | This work was supported by grants from the Spanish Ministry of Education and Science SAF2011-27442, Fundació La Marato de TV3 (ref. 100130) and an ACCI2012 action from CIBERER. A.B. holds a postdoctoral fellowship from the Program “Junta para la Ampliación de Estudios” (JAE-Doc) co-funded by the European Social Fund (ESF). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Springer Nature | es_ES |
dc.relation.isversionof | Postprint | es_ES |
dc.rights | openAccess | es_ES |
dc.subject | Lafora disease | es_ES |
dc.subject | Polyglucosan accumulation | es_ES |
dc.subject | Metformin | es_ES |
dc.subject | 4-phenylbutyric acid | es_ES |
dc.subject | Trehalose | es_ES |
dc.subject | Pharmacological intervention | es_ES |
dc.title | Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1007/s12035-015-9091-8 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1007/s12035-015-9091-8 | es_ES |
dc.identifier.e-issn | 1559-1182 | - |
dc.contributor.funder | Ministerio de Educación y Ciencia (España) | es_ES |
dc.contributor.funder | Fundació La Marató de TV3 | es_ES |
dc.contributor.funder | European Science Foundation | es_ES |
dc.relation.csic | Sí | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/100008666 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100000782 | es_ES |
dc.identifier.pmid | 25627694 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.grantfulltext | open | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
Aparece en las colecciones: | (IBV) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Berthier et al 2016 Mol Neurobiol.pdf | Artículo principal | 2,5 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
36
checked on 27-feb-2024
SCOPUSTM
Citations
52
checked on 23-mar-2024
WEB OF SCIENCETM
Citations
49
checked on 25-feb-2024
Page view(s)
232
checked on 29-mar-2024
Download(s)
276
checked on 29-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.